Locations:
SearchAdvertisement
Specificity in study criteria yields sleep disorder insights
A co-author explains some of the key McDonald criteria revisions
The BTK inhibitor tolebrutinib meets its primary endpoint in phase 3 HERCULES trial
Meaningful characterization is critical to advancing research and care, review authors contend
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Guidance from international committee on differential diagnoses and diagnostic approach
Investigational gene approaches offer hope for a therapeutically challenging condition
$3.2 million grant will fund use of calcium-based imaging to record neuronal activity in ischemia model
Findings from large cohort analysis can guide ongoing quality improvement initiatives
New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities
Helping patients, families navigate the complexities of psychosis
Advertisement
Advertisement